IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i16p10220-d890633.html
   My bibliography  Save this article

Determinants of Survival of HIV Patients Receiving Dolutegravir: A Prospective Cohort Study in Conflict-Affected Bunia, Democratic Republic of Congo

Author

Listed:
  • Roger T. Buju

    (Department of Public Health, Faculty of Medicine, University of Bunia, Bunia P.O. Box 292, Congo)

  • Pierre Z. Akilimali

    (Department of Biostatistics and Epidemiology, Kinshasa School of Public Health, University of Kinshasa, Kinshasa P.O. Box 11850, Congo)

  • Nguyen-Toan Tran

    (Australian Centre for Public and Population Health Research, Faculty of Health, University of Technology Sydney, P.O. Box 123, Sydney, NSW 2007, Australia
    Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1206 Genève, Switzerland)

  • Erick N. Kamangu

    (Département des Sciences de Base, School of Medicine, University of Kinshasa, Kinshasa P.O. Box 11850, Congo)

  • Gauthier K. Mesia

    (Unité de Pharmacologie Clinique et Pharmacovigilance, School of Medicine, University of Kinshasa, Kinshasa P.O. Box 11850, Congo)

  • Jean Marie N. Kayembe

    (Department Internal Medicine, School of Medicine, University of Kinshasa, Kinshasa P.O. Box 11850, Congo)

  • Hippolyte N. Situakibanza

    (Department Internal Medicine, School of Medicine, University of Kinshasa, Kinshasa P.O. Box 11850, Congo
    Department of Tropical Medicine, Infectious and Parasitic Diseases, School of Medicine, University of Kinshasa, Kinshasa P.O. Box 11850, Congo)

Abstract

This study aims to determine the factors influencing HIV-related mortality in settings experiencing continuous armed conflict atrocities. In such settings, people living with HIV (PLHIV), and the partners of those affected may encounter specific difficulties regarding adherence to antiretroviral therapy (ART), and retention in HIV prevention, treatment, and care programs. Between July 2019 and July 2021, we conducted an observational prospective cohort study of 468 PLHIV patients treated with Dolutegravir at all the ART facilities in Bunia. The probability of death being the primary outcome, as a function of time of inclusion in the cohort, was determined using Kaplan–Meier plots. We used the log-rank test to compare survival curves and Cox proportional hazard modeling to determine mortality predictors from the baseline to 31 July 2021 (endpoint). The total number of person-months (p-m) was 3435, with a death rate of 6.70 per 1000 p-m. Compared with the 35-year-old reference group, older patients had a higher mortality risk. ART-naïve participants at the time of enrollment had a higher mortality risk than those already using ART. Patients with a high baseline viral load (≥1000 copies/mL) had a higher mortality risk compared with the reference group (adjusted hazard ratio = 6.04; 95% CI: 1.78–20.43). One-fourth of deaths in the cohort were direct victims of armed conflict, with an estimated excess death of 35.6%. Improving baseline viral load monitoring, starting ART early in individuals with high baseline viral loads, the proper tailoring of ART regimens and optimizing long-term ART, and care to manage non-AIDS-related chronic complications are recommended actions to reduce mortality. Not least, fostering women’s inclusion, justice, peace, and security in conflict zones is critical in preventing premature deaths in the general population as well as among PLHIV.

Suggested Citation

  • Roger T. Buju & Pierre Z. Akilimali & Nguyen-Toan Tran & Erick N. Kamangu & Gauthier K. Mesia & Jean Marie N. Kayembe & Hippolyte N. Situakibanza, 2022. "Determinants of Survival of HIV Patients Receiving Dolutegravir: A Prospective Cohort Study in Conflict-Affected Bunia, Democratic Republic of Congo," IJERPH, MDPI, vol. 19(16), pages 1-10, August.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:16:p:10220-:d:890633
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/16/10220/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/16/10220/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Roger T. Buju & Pierre Z. Akilimali & Erick N. Kamangu & Gauthier K. Mesia & Jean Marie N. Kayembe & Hippolyte N. Situakibanza, 2022. "Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study," IJERPH, MDPI, vol. 19(8), pages 1-9, April.
    2. Roger T. Buju & Pierre Z. Akilimali & Erick N. Kamangu & Gauthier K. Mesia & Jean Marie N. Kayembe & Hippolyte N. Situakibanza, 2022. "Predictors of Viral Non-Suppression among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study," IJERPH, MDPI, vol. 19(3), pages 1-13, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Roger T. Buju & Pierre Z. Akilimali & Erick N. Kamangu & Gauthier K. Mesia & Jean Marie N. Kayembe & Hippolyte N. Situakibanza, 2022. "Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study," IJERPH, MDPI, vol. 19(8), pages 1-9, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:16:p:10220-:d:890633. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.